Characteristics | Poor outcome | p value | |
---|---|---|---|
No | Yes | ||
Age, years, mean (SD) | 66.90 ± 12.68 | 74.17 ± 13.09 | < 0.001 |
Female, (%) | 140 (41.18%) | 92 (50.83%) | 0.035 |
Hypertension, (%) | 285 (83.82%) | 160 (88.40%) | 0.159 |
Diabetes, (%) | 77 (22.65%) | 50 (27.62%) | 0.208 |
Hyperlipidemia, (%) | 147 (43.24%) | 62 (34.25%) | 0.046 |
Previous stroke, (%) | 49 (14.41%) | 47 (25.97%) | 0.001 |
Coronary heart disease, (%) | 20 (5.88%) | 31 (17.13%) | < 0.001 |
Atrial fibrillation, (%) | 29 (8.53%) | 57 (31.49%) | < 0.001 |
Current cigarette smoking, (%) | 33 (9.71%) | 21 (11.60%) | 0.499 |
NIHSS, median (IQR) | 2 (1–3) | 7.00 (4–11) | < 0.001 |
Premorbid mRS score, median (IQR) | 0 (0–0) | 0 (0–0) | 0.065 |
Stroke subtypes | < 0.001 | ||
Large artery atherosclerosis | 108 (31.76%) | 80 (44.20%) | |
Cardioembolic stroke | 25 (7.35%) | 52 (28.73%) | |
Small artery disease | 201 (59.12%) | 49 (27.07%) | |
Other etiology/unknown | 6 (1.76%) | 0 (0.00%) | |
IV rtPA, (%) | 29 (8.53%) | 16 (8.84%) | 0.904 |
Proton pump inhibitors | 106 (31.18%) | 107 (59.12%) | < 0.001 |
Triglyceride, mmol/L, median (IQR) | 1.46 (1.02–2.03) | 1.21 (0.94–1.67) | 0.001 |
Total cholesterol, mmol/L, mean (SD) | 4.91 ± 1.45 | 4.94 ± 1.15 | 0.765 |
High-density lipoprotein cholesterol, mmol/L, mean (SD) | 1.29 ± 0.37 | 1.33 ± 0.38 | 0.289 |
Low-density lipoprotein cholesterol, mmol/L, mean (SD) | 2.46 ± 0.74 | 2.50 ± 0.74 | 0.577 |
EMR, median (IQR) | 0.22 (0.10–0.39) | 0.12 (0.05–0.23) | < 0.001 |